|Bid||46.25 x 200|
|Ask||47.63 x 100|
|Day's Range||45.64 - 47.59|
|52 Week Range||37.35 - 55.38|
|PE Ratio (TTM)||-20.59|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Q1 2017 Neurocrine Biosciences Inc Earnings Call
During the week ended May 26, 2017, Alexion Pharmaceuticals (ALXN) saw the biggest loss in the healthcare sector. ALXN's stock price witnessed a steep fall of ~14.2%.
The biotech sector as measured by the iShares Nasdaq Biotech ETF is down another 1.40% today.